First drug-eluting coronary stent approved.
Thompson
Cheryl A
CA
D023903:Coronary Restenosis / Q000517:prevention & control*; D018795:Device Approval; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D020123:Sirolimus / Q000008:administration & dosage*; D015607:Stents; D014481:United States; D014486:United States Food and Drug Administration
D007166:Immunosuppressive Agents; D020123:Sirolimus